Dow Jones

52 284,94

-1,21%

Germany 40

Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.

Accueil
Investir
Actions
Etats-Unis
NASDAQ
Adagio Medical Holdings Inc (ADGM)
Adagio Medical Holdings Inc (ADGM) Actualités

Adagio Medical Holdings Inc (ADGM)

0,59

-0,022

( -3,59% )

Mis à jour : 18:52:22

Outils de qualité professionnelle, pour des investisseurs individuels.

Premium

Adagio Medical Submits Premarket Approval Application to FDA for vCLAS® Ventricular Ablation System for the Treatment of Ventricular Tachycardia

PMA Submission Supported by FULCRUM-VT Pivotal Trial Data — 209 Patients Across 20 Leading Centers; Breakthrough Device Designation Previously...

Adagio Medical Reports First Quarter 2026 Results and Meaningful Clinical Progress

Advancing Toward Submission for PMA Approval Following Late-Breaking FULCRUM-VT Data Adagio Medical Holdings, Inc (Nasdaq: ADGM) (“Adagio” or...

Adagio Medical to Participate in the BofA Securities 2026 Health Care Conference

Adagio Medical Holdings, Inc. (Nasdaq: ADGM) (“Adagio” or “the Company”), a leading innovator in catheter ablation technologies for the treatment...

Adagio Medical Announces Positive Pivotal Results for vCLAS® Ventricular Ablation System

84% Freedom From Shock and 59% Freedom From VT Recurrence in FULCRUM-VT Pivotal IDE Trial Meet Safety and Effectiveness Endpoints and Replicate...

Adagio Medical’s ULTA Technology to Be Featured at the Heart Rhythm 2026 Conference

Use of ULTA Across Broad Spectrum of Ventricular Tachycardias to be Highlighted in Multiple Scientific Presentations, Including Late-Breaking...

Adagio Medical secures FDA clearance to broaden ventricular ablation study

Adagio Medical Holdings Inc. (NASDAQ:ADGM) said it has received Investigational Device Exemption (IDE) authorization from the U.S. Food and Drug...

Adagio Medical Receives IDE Approval from the FDA to Investigate Next-Generation vCLAS® Ventricular Ablation System

Designed to Deliver Faster, More Efficient Ablation with Improved Usability on Established, Titratable, Endocardial-Approach ULTA Platform Adagio...

Adagio Medical to Participate in the 25th Annual Needham Virtual Conference

Adagio Medical Holdings, Inc. (Nasdaq: ADGM) (“Adagio” or “the Company”), a leading innovator in catheter ablation technologies for the treatment...

Adagio Medical Ultralow Temperature Ablation U.S. Pivotal Study Results to be Presented in Late-Breaking Session at Heart Rhythm Society 2026

Adagio Medical Holdings, Inc. (Nasdaq: ADGM) (“Adagio” or “the Company”), a leading innovator in catheter ablation technologies for the treatment...

Adagio Medical Reports Fourth Quarter and Full Year 2025 Results

Adagio Medical Holdings, Inc. (Nasdaq: ADGM) (“Adagio” or “the Company”), a leading innovator in catheter ablation technologies for the treatment...

Adagio Medical Announces Publication of Pre-Clinical Results for Next Generation Ventricular Ablation Catheter

Highlights Improvements in Next Generation ULTA Catheter, Including Potential 50-75% Reduction in Ablation Time Adagio Medical Holdings, Inc...

Adagio Medical Highlights Recent Successful Expanded Access Cases with vCLAS™ System, Including Patients with Premature Ventricular Contractions (PVC)

vCLASTM Used to Treat Patients with No Satisfactory Approved Treatment and/or Failed RF or PFA Adagio Medical Holdings, Inc. (Nasdaq: ADGM...

Adagio Medical to Participate in the 38th Annual Roth Conference

Adagio Medical Holdings, Inc. (Nasdaq: ADGM) (“Adagio” or “the Company”), a leading innovator in catheter ablation technologies for the treatment...

Adagio Medical to Participate in the TD Cowen 46th Annual Healthcare Conference

Adagio Medical Holdings, Inc. (Nasdaq: ADGM) (“Adagio” or “the Company”), a leading innovator in catheter ablation technologies for the treatment...

Small Cap Growth Virtual Investor Conference: Presentations Now Available for On-Demand Viewing

NEW YORK, Feb. 06, 2026 (GLOBE NEWSWIRE) -- Virtual Investor Conferences, the leading proprietary investor...

Forums

Afficher les forums

Aucune Discussion Trouvée

Ajouter une Discussion

Minor Hotels Europe & Am...

TG

A383QQ

Bond 3125% until 27.08.2...

EU

ORADE

Domestic Bond 3.875% 11s...

Peo Alphaquest Thematic ...

Food and Life Companies (PK)

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

Vous avez déjà un compte? Connexion

Vous n'avez pas de compte ? Inscription

En m'inscrivant, je confirme avoir lu, compris et accepté les Conditions générales d'ADVFN et j'affirme etre un investisseur privé.

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

Adagio Medical Holdings Inc (ADGM)

Outils de qualité professionnelle, pour des investisseurs individuels.